AUTH/2919/12/16: Anonymous (non-contactable) v Merck Sharp & Dohme — no breach (representative conduct allegation)

📅 2016 | 🖉 Dr Anzal Qurbain
📊

Key facts

Case numberAUTH/2919/12/16
PartiesAnonymous, non-contactable complainant v Merck Sharp & Dohme
IssueAlleged conduct of representative (bringing daughter to meetings)
Complaint received14 December 2016
Case completed20 January 2017
Applicable Code year2016
Clauses considered2, 9.1, 15.2
DecisionNo breach
AppealNo appeal
SanctionsNone stated

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • An anonymous, non-contactable complainant (stating they were a GP) alleged a named Merck Sharp & Dohme (MSD) representative used to bring her daughter to meetings.
  • The complainant alleged a verbal complaint had been made to the representative’s manager and that the representative left the company.
  • The PMCPA asked MSD to bear in mind Clauses 2, 9.1 and 15.2 of the Code.
  • MSD reviewed the representative’s employment dates, interviewed the line manager, and reviewed the HR file.
  • MSD stated there was no record that any verbal or written complaint had been received by the manager about the daughter attending meetings/functions, and no disciplinary proceedings had been taken.
  • MSD stated the representative resigned voluntarily to take a position at another company.
⚖️

Outcome

  • No breach of the Code.
  • The Panel found the complainant had not shown, on the balance of probabilities, that the representative failed to maintain a high standard of ethical conduct.
  • The Panel did not consider MSD had failed to maintain a high standard, brought discredit upon, or reduced confidence in the industry.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training